Mari Kanerva
Impact in
-
- Antibiotic Use and Resistance
- Infectious Diseases top 5%
- Viral Infections and Vectors
- Viral Infections and Outbreaks Research
- Antimicrobial Resistance in Staphylococcus
Papers in
-
- Antibiotic Use and Resistance 4
-
- Viral Infections and Vectors 13
- Antimicrobial Resistance in Staphylococcus 6
- Co-authors
- Outi LyytikäinenOlli VapalahtiJukka OllgrenMikko VirtanenIlkka JulkunenKrister MelénAntti VaheriK Pietilä
- Journals
- Journal of Hospital Infection (3 papers)PLoS ONE (3 papers)Frontiers in Immunology (2 papers)Epidemiology and Infection (2 papers)Clinical Infectious Diseases (1 paper)
- Partner nations
- FinlandSwedenUnited States
In The Last Decade
Mari Kanerva
38 papers receiving 567 citations
Peers
Comparison fields: 5 of 80
- Applied Microbiology and Biotechnology 57
- Infectious Diseases 432
- Critical Care and Intensive Care Medicine 61
- Parasitology 55
- Global and Planetary Change 165
Countries citing papers authored by Mari Kanerva
This map shows the geographic impact of Mari Kanerva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mari Kanerva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mari Kanerva more than expected).
Fields of papers citing papers by Mari Kanerva
This network shows the impact of papers produced by Mari Kanerva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mari Kanerva. The network helps show where Mari Kanerva may publish in the future.
Co-authors
The 25 scholars most cited alongside Mari Kanerva, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 5 | |
| 8 | 2022 | 2 | |
| 9 | Epidemiology of laboratory-confirmed influenza among kidney transplant recipients compared to the general population : A nationwide cohort study | 2021 | 0 |
| 10 | 2021 | 4 | |
| 11 | 2021 | 2 | |
| 12 | 2020 | 10 | |
| 13 | Hoitoon liittyvien infektioiden prevalenssi HUS-alueen terveyskeskussairaaloissa 2015 | 2018 | 1 |
| 14 | 2018 | 10 | |
| 15 | 2015 | 5 | |
| 16 | 2012 | 9 | |
| 17 | Disease burden of Puumala virus infections, 1995-2008 | 2010 | 1 |
| 18 | Human Cases of Methicillin-Resistant Staphylococcus aureus CC398 Infection, Finland | 2010 | 2 |
| 19 | 2009 | 2 | |
| 20 | 1996 | 90 |
About Mari Kanerva
Mari Kanerva is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases, Parasitology, Critical Care and Intensive Care Medicine and Clinical Biochemistry, having authored 49 papers that have together received 606 indexed citations. Recurring topics across this work include Viral Infections and Vectors (13 papers), Vector-borne infectious diseases (9 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Long-Term Effects of COVID-19 (6 papers), Patient Satisfaction in Healthcare (5 papers), Bacterial Identification and Susceptibility Testing (5 papers), Bacterial biofilms and quorum sensing (4 papers) and Antibiotic Use and Resistance (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (57 citations), Infectious Diseases (432 citations), Critical Care and Intensive Care Medicine (61 citations), Parasitology (55 citations) and Global and Planetary Change (165 citations). Mari Kanerva has collaborated with scholars based in Finland, Sweden and United States. Frequent co-authors include Outi Lyytikäinen, Olli Vapalahti, Jukka Ollgren, Mikko Virtanen, Ilkka Julkunen, Krister Melén, Antti Vaheri, K Pietilä, Amos Pasternack and Jukka Mustonen. Their work appears in journals such as Journal of Hospital Infection, PLoS ONE, Frontiers in Immunology, Epidemiology and Infection and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.